Dave Matthews Band has revealed plans for an extended winter tour! The beloved jam group has some major plans for summer 2016, with a four-month-long tour that kicks off May 11th and ends with a three-night run at The Gorge in George, WA over Labor Day weekend.While this tour is certainly extensive, the band has some unfortunate news to share with fans as well. In the announcement, DMB reveals that they “will take a break from touring in 2017.” The full message from DMB can be read below, which includes pre-sale and full on sale information. The full schedule of 2016 dates follows:We are excited to hit the road this summer and celebrate our 25th anniversary. The 2016 North American tour will launch on May 11th in Wichita, KS and conclude at The Gorge Amphitheatre for the traditional Labor Day weekend run on September 2nd, 3rd and 4th. Visit http://davematthewsband.com/tour for the full list of summer tour dates.We will take a break from touring in 2017. We are so appreciative of our amazing fans and want to thank you all for your continued support. See you this summer!The Warehouse presale will begin on Tuesday, January 26th at 10 am ET and will offer general tickets, exclusive Premium Packages, Premier Parking and Camping. The Warehouse offers early entry privileges (subject to venue restrictions) in addition to opportunities for General Admission Pit upgrades and meet & greets. Click here to join The Warehouse.Tickets for the Dave Matthews Band via Public Sale opens Friday, February 19th at noon Local Venue Time.Dave Matthews Band Tour ScheduleMay 11 INTRUST Bank Arena – Wichita, Kansas, USMay 13 The Cynthia Woods Mitchell Pavilion – The Woodlands, Texas, USMay 14 Gexa Energy Pavilion – Dallas, Texas, USMay 17 Chesapeake Energy Arena – Oklahoma City, Oklahoma, USMay 18 Verizon Arena – North Little Rock, Arkansas, USMay 20 Riverbend Music Center – Cincinnati, Ohio, USMay 21 Blossom Music Center – Cuyahoga Falls, Ohio, USMay 24 Oak Mountain Amphitheatre – Pelham, Alabama, USMay 27 PNC Music Pavilion Charlotte – Charlotte, North Carolina, USMay 28 Aaron’s Amphitheatre at Lakewood – Atlanta, Georgia, USMay 29 Hollywood Casino Amphitheatre – Maryland Heights, Missouri, USJun 07 PNC Bank Arts Center – Holmdel, New Jersey, USJun 08 Darling’s Waterfront Pavilion – Bangor, Maine, USJun 10 Xfinity Center – Mansfield, Massachusetts, USJun 11 Xfinity Theatre – Hartford, Connecticut, USJun 17 Veterans United Amphitheater – Virginia Beach, Virginia, USJun 18 Jiffy Lube Live – Bristow, Virginia, USJun 21 Nikon at Jones Beach Theater – Wantagh, New York, USJun 22 Lakeview Amphitheatre – Syracuse, New York, USJun 24 BB&T Pavilion – Camden, New Jersey, USJun 25 BB&T Pavilion – Camden, New Jersey, USJun 28 iWireless Center – Moline, Illinois, USJun 29 Cricket Wireless Amphitheatre – Bonner Springs, Kansas, USJul 01 Alpine Valley Music Theatre – East Troy, Wisconsin, USJul 02 Alpine Valley Music Theatre – East Troy, Wisconsin, USJul 08 Nationwide Arena – Columbus, Ohio, USJul 09 First Niagara Pavilion – Burgettstown, Pennsylvania, USJul 12 Bank of NH Pavilion – Gilford, New Hampshire, USJul 13 Bank of NH Pavilion – Gilford, New Hampshire, USJul 15 Saratoga Performing Arts Center – Saratoga Springs, New York, USJul 16 Saratoga Performing Arts Center – Saratoga Springs, New York, USJul 19 Molson Amphitheatre – Toronto, Ontario, CAJul 20 DTE Energy Music Theatre – Clarkston, Michigan, USJul 22 Klipsch Music Center – Noblesville, Indiana, USJul 23 Klipsch Music Center – Noblesville, Indiana, USJul 26 North Charleston Coliseum – North Charleston, South Carolina, USJul 27 MIDFLORIDA Credit Union Amphitheatre – Tampa, Florida, USJul 29 Perfect Vodka Amphitheatre at the South Florida Fairgrounds – West Palm Beach, Florida, USJul 30 Perfect Vodka Amphitheatre at the South Florida Fairgrounds – West Palm Beach, Florida, USAug 26 Sleep Train Amphitheatre – Chula Vista, California, USAug 27 Irvine Meadows Amphitheater – Irvine, California, USAug 29 University of California, Berkeley – Greek Theatre Berkeley, California, US Aug 30 University of California, Berkeley – Greek Theatre Berkeley, California, USSep 02 Gorge Amphitheatre – George, Washington, USSep 03 Gorge Amphitheatre – George, Washington, USSep 04 Gorge Amphitheatre – George, Washington, US
March 15, 2007 Regular News ABA’s Fellows honor Sonnet A BA’s Fellows honor SonnetNeal R. Sonnet of Miami received the Outstanding Service Award for 2007 from The Fellows of the American Bar Foundation at its recent meeting in Miami.The Outstanding Service Award was first awarded by the fellows in 1957 and is given to a fellow who has adhered for more than 30 years to the “highest principles and traditions of the legal profession and to the service of the public.”Among his many accomplishments, Sonnet is a former president of The Florida Bar Foundation, served on a panel to improve community confidence in the criminal justice system after Miami’s “McDuffie Riots” in 1980, chaired the 2002-04 ABA Task Force on Treatment of Enemy Combatants, and was named the ABA’s official observer for the military commission trials in Guantanamo.The Fellows of the American Bar Foundation is an honorary organization of attorneys, judges, and law professors whose professional, public, and private careers have demonstrated outstanding dedication to the welfare of their communities and to the highest principles of the legal profession.
UA News:TUCSON, Ariz. — Findings from an investigative study at the Center for Innovation in Brain Science at the University of Arizona Health Sciences have shown that, for women with breast cancer, exposure to hormone-modulating therapies was associated with a significant decrease in the number of women who received a diagnosis of neurodegenerative disease – more specifically Alzheimer’s disease.The center’s investigation, which was published in JAMA Network Open this past spring, surveyed medical insurance claims from private-payer and Medicare data to identify premenopausal, menopausal or postmenopausal patients who had been diagnosed with breast cancer to determine whether those women receiving hormone-modulating therapies had a different risk of developing a neurodegenerative disease. “This retrospective cohort study provides a clear message: breast cancer therapies do not increase the risk of age-related neurodegenerative diseases, like Alzheimer’s and Parkinson’s. Critically, these therapies can actually reduce the risk of developing these diseases, ” said Center Director Roberta Diaz Brinton, PhD. “As life expectancies after treatment increase for breast cancer patients, this study further illustrates the importance of evaluating personalized treatment options that may result in a reduced risk of neurodegenerative diseases like Alzheimer’s.”According 2019 statistics from BreastCancer.org, breast cancer is the second most common cancer in women and 12.8% of women (1 in 8) will receive a breast cancer diagnosis in their lifetime. It is predicted the number of women living with breast cancer and at risk for other diseases will escalate, in the aging population especially. At the same time, women are at a two-fold greater lifetime risk than men for developing Alzheimer’s disease. The study’s lead author, Gregory Branigan, a predoctoral fellow, is part of the UArizona MD/PhD Program, which offers dual training in both medicine and biomedical research, and is conducting his doctoral research in Dr. Brinton’s laboratory. Collaborators include Kathleen Rodgers, PhD, Maira Soto, PhD, and noted breast cancer surgeon Leigh Neumayer, MD, former surgery department head at the UArizona College of Medicine – Tucson now at the University of Florida College of Medicine in Jacksonville.Dr. Brinton also is a UArizona professor in the Department of Neurology and Pharmacology in the College of Medicine – Tucson and Department of Psychology in the UArizona College of Science. The UArizona Center for Innovation in Brain Science continues to pursue research through an innovative “all brains on deck” approach, in order to reduce the global burden of Alzheimer’s and other neurodegenerative diseases.This study was supported by grants from the National Institute on Aging: Perimenopause in Brain Aging and Alzheimer’s Disease (P01AG026572); Translational Research in Alzheimer’s Disease and Related Dementias – TRADD (T32AG061897); and Aging and Estrogenic Control of the Bioenergetic System in Brain (R37AG053589); and funding from the Women’s Alzheimer’s Movement to Dr. Brinton’s research.